There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on May 7, ChemoCentryx, Inc.'s EVP, Chief Operating Officer, Tausif Butt, invested $120,240.68 into 10,870 shares of CCXI, for a cost per share of $11.06..